Evidence map›Paper›PMID 33683562›Full record

ArticleIrish journal of medical science2022

Minding metabolism: targeted interventions to improve cardio-metabolic monitoring across early and chronic psychosis.

John R Kelly, Priyola Gounden, Aoibheann McLoughlin, Zahra Legris, Therese O'Carroll, Roisin McCafferty, Liliana Marques, Maeve Haran, Richard Farrelly, Karen Loughrey and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Irish journal of medical science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

John R KellyTallaght University Hospital, Dublin, Ireland. kellyjr@tcd.ie.ORCID http://orcid.org/0000-0002-9545-0615
Priyola GoundenPsychosis Unit, Gavle, Sweden.
Aoibheann McLoughlinTallaght University Hospital, Dublin, Ireland.
Zahra LegrisDepartment of Psychiatry, St. James's Hospital, Dublin, Ireland.
Therese O'CarrollMeath Mental Health Services, An Táin, Navan, Meath, Ireland.
Roisin McCaffertyPsychiatry of Old Age, Beaumont Hospital, Dublin, Ireland.
Liliana MarquesSt. Vincent's Hospital, Dublin, Ireland.
Maeve HaranDaughters of Charity Disability Services, Navan Road, Dublin, Ireland.
Richard FarrellyTallaght University Hospital, Dublin, Ireland.
Karen LoughreyDepartment of Psychiatry, St. James's Hospital, Dublin, Ireland.
Gráinne FlynnTrinity Institute of Neurosciences, Trinity College Dublin, Dublin, Ireland.
Aiden CorvinDepartment of Psychiatry, St. James's Hospital, Dublin, Ireland.
Catherine DolanDepartment of Psychiatry, Sligo/Leitrim Mental Health Services, Sligo, Ireland.ORCID http://orcid.org/0000-0001-7694-0283
Tallaght University Hospital · IESt. James's Hospital · IETrinity College Dublin · IEBeaumont Hospital · IEGävle Hospital · SESligo University Hospital · IESt. Vincent's University Hospital · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAntipsychotics (APs) increase weight, metabolic syndrome, diabetes and cardiovascular disease. Guidelines recommend cardio-metabolic monitoring at initial assessment, at 3 months and then annually in people prescribed APs.

aimTo determine the rates of cardio-metabolic monitoring in AP treated early and chronic psychosis and to assess the impact of targeted improvement strategies.

methodsMedical records were reviewed in two cohorts of first-episode psychosis (FEP) patients before and after the implementation of a physical health parameter checklist and electronic laboratory order set. In a separate group of patients with chronic psychotic disorders, adherence to annual monitoring was assessed before and 3 months after an awareness-raising educational intervention.

resultsIn FEP, fasting glucose (39% vs 67%, p=0.05), HbA1c (0% vs 24%, p=0.005) and prolactin (18% vs 67%, p=0.001) monitoring improved. There were no significant differences in weight (67% vs 67%, p=1.0), BMI (3% vs 10%, p=0.54), waist circumference (3% vs 0%, p=1.0), fasting lipids (61% vs 76% p=0.22) or ECG monitoring (67% vs 67%, p=1.0). Blood pressure (BP) (88% vs 57%, p=0.04) and heart rate (91% vs 65%, p=0.03) monitoring dis-improved. Diet (0%) and exercise (<15%) assessment was poor. In chronic psychotic disorders, BP monitoring improved (20% vs 41.4%, p=0.05), whereas weight (17.0% vs 34.1%, p=0.12), BMI (9.7% vs 12.1%, p=1.0), fasting glucose (17% vs 24.3%, p=0.58) and fasting lipids remained unchanged (17% vs 24.3%, p=0.58).

conclusionsTargeted improvement strategies resulted in a significant improvement in a limited number of parameters in early and chronic psychotic disorders. Overall, monitoring remained suboptimal.

Indexed as

Antipsychotic AgentsPsychotic DisordersExerciseHumansLipidsAntipsychotic AgentsLipidsAntipsychoticsCardio-metabolic riskFirst-episode psychosisMetabolic syndromePsychosisRoutine monitoringSchizophrenia

Identifiers

PMID33683562
PMCPMC7938026
OpenAlexW3134154254

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.